Korean Hereditary Breast Cancer Study
1. To find founder mutation in Korean
2. To correlation prevalence with risk evaluation
3. To find risk factors concerning life style
Observational
Observational Model: Cohort, Time Perspective: Prospective
Find out the prevalence of BRCA1/2 mutation of high risk breast cancer patients
6 years
Yes
Sung-Won Kim, M.D, Ph.D.
Principal Investigator
Department of Surgery, Breast & Endocrine Service, Seoul National University Bundang Hospital
Korea: Food and Drug Administration
KBCSG003
NCT00595348
November 2007
May 2017
Name | Location |
---|